| Dr Sajid Mehmood, MD | |
|
6800 State Route 162, Maryville, IL 62062-8521 | |
| (618) 288-5711 | |
| (618) 288-4088 |
| Full Name | Dr Sajid Mehmood |
|---|---|
| Gender | Male |
| Speciality | Critical Care (intensivists) |
| Experience | 34 Years |
| Location | 6800 State Route 162, Maryville, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467444950 | NPI | - | NPPES |
| 207281304 | Medicaid | MO |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Hospital And Medical Center | Chicago, IL | Hospital |
| Waukesha Memorial Hospital | Waukesha, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Insight Chicago Inc | 2860894706 | 114 |
News Archive
A drug typically used to treat depression and anxiety can significantly reduce joint pain in postmenopausal women being treated for early stage breast cancer, according to new SWOG research to be presented Friday at a special plenary presentation at the San Antonio Breast Cancer Symposium.
Scientists are reporting an in-depth validation of the discovery of the world's first mass producible, low-cost, organoclays for plastics. The powdered material, made from natural clay, would be a safer, more environmentally friendly replacement for the compound widely used to make plastics nanocomposites. A report on the research appears in ACS' Macromolecules, a bi-weekly journal.
The Bismarck Tribune reports on a new scheme "asking seniors to pay up for not having Part D coverage. The scammers have been calling beneficiaries saying they owe a penalty for not having the Part D prescription drug coverage and that they need to pay the fine right away, said a release from the office of the Insurance Commissioner" (1/20).
In a recent study, scientists from the Institute for Cancer Research at MedUni Vienna have shown that the growth factor receptor FGFR3 increases the rate of growth and aggressiveness of hepatocellular carcinomas (liver cell cancer). Inhibition of this receptor could be a new and effective way of treating patients.
› Verified 3 days ago
| Entity Name | The Board Of Trustees Of The University Of Illinois |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386863819 PECOS PAC ID: 3072422716 Enrollment ID: O20031112000158 |
News Archive
A drug typically used to treat depression and anxiety can significantly reduce joint pain in postmenopausal women being treated for early stage breast cancer, according to new SWOG research to be presented Friday at a special plenary presentation at the San Antonio Breast Cancer Symposium.
Scientists are reporting an in-depth validation of the discovery of the world's first mass producible, low-cost, organoclays for plastics. The powdered material, made from natural clay, would be a safer, more environmentally friendly replacement for the compound widely used to make plastics nanocomposites. A report on the research appears in ACS' Macromolecules, a bi-weekly journal.
The Bismarck Tribune reports on a new scheme "asking seniors to pay up for not having Part D coverage. The scammers have been calling beneficiaries saying they owe a penalty for not having the Part D prescription drug coverage and that they need to pay the fine right away, said a release from the office of the Insurance Commissioner" (1/20).
In a recent study, scientists from the Institute for Cancer Research at MedUni Vienna have shown that the growth factor receptor FGFR3 increases the rate of growth and aggressiveness of hepatocellular carcinomas (liver cell cancer). Inhibition of this receptor could be a new and effective way of treating patients.
› Verified 3 days ago
| Entity Name | Decatur Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164477725 PECOS PAC ID: 6204731144 Enrollment ID: O20031203000685 |
News Archive
A drug typically used to treat depression and anxiety can significantly reduce joint pain in postmenopausal women being treated for early stage breast cancer, according to new SWOG research to be presented Friday at a special plenary presentation at the San Antonio Breast Cancer Symposium.
Scientists are reporting an in-depth validation of the discovery of the world's first mass producible, low-cost, organoclays for plastics. The powdered material, made from natural clay, would be a safer, more environmentally friendly replacement for the compound widely used to make plastics nanocomposites. A report on the research appears in ACS' Macromolecules, a bi-weekly journal.
The Bismarck Tribune reports on a new scheme "asking seniors to pay up for not having Part D coverage. The scammers have been calling beneficiaries saying they owe a penalty for not having the Part D prescription drug coverage and that they need to pay the fine right away, said a release from the office of the Insurance Commissioner" (1/20).
In a recent study, scientists from the Institute for Cancer Research at MedUni Vienna have shown that the growth factor receptor FGFR3 increases the rate of growth and aggressiveness of hepatocellular carcinomas (liver cell cancer). Inhibition of this receptor could be a new and effective way of treating patients.
› Verified 3 days ago
| Entity Name | Central Dupage Physician Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033149844 PECOS PAC ID: 5890696231 Enrollment ID: O20040303000601 |
News Archive
A drug typically used to treat depression and anxiety can significantly reduce joint pain in postmenopausal women being treated for early stage breast cancer, according to new SWOG research to be presented Friday at a special plenary presentation at the San Antonio Breast Cancer Symposium.
Scientists are reporting an in-depth validation of the discovery of the world's first mass producible, low-cost, organoclays for plastics. The powdered material, made from natural clay, would be a safer, more environmentally friendly replacement for the compound widely used to make plastics nanocomposites. A report on the research appears in ACS' Macromolecules, a bi-weekly journal.
The Bismarck Tribune reports on a new scheme "asking seniors to pay up for not having Part D coverage. The scammers have been calling beneficiaries saying they owe a penalty for not having the Part D prescription drug coverage and that they need to pay the fine right away, said a release from the office of the Insurance Commissioner" (1/20).
In a recent study, scientists from the Institute for Cancer Research at MedUni Vienna have shown that the growth factor receptor FGFR3 increases the rate of growth and aggressiveness of hepatocellular carcinomas (liver cell cancer). Inhibition of this receptor could be a new and effective way of treating patients.
› Verified 3 days ago
| Entity Name | Illinois Hospitalists Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871832931 PECOS PAC ID: 8224275862 Enrollment ID: O20130520000092 |
News Archive
A drug typically used to treat depression and anxiety can significantly reduce joint pain in postmenopausal women being treated for early stage breast cancer, according to new SWOG research to be presented Friday at a special plenary presentation at the San Antonio Breast Cancer Symposium.
Scientists are reporting an in-depth validation of the discovery of the world's first mass producible, low-cost, organoclays for plastics. The powdered material, made from natural clay, would be a safer, more environmentally friendly replacement for the compound widely used to make plastics nanocomposites. A report on the research appears in ACS' Macromolecules, a bi-weekly journal.
The Bismarck Tribune reports on a new scheme "asking seniors to pay up for not having Part D coverage. The scammers have been calling beneficiaries saying they owe a penalty for not having the Part D prescription drug coverage and that they need to pay the fine right away, said a release from the office of the Insurance Commissioner" (1/20).
In a recent study, scientists from the Institute for Cancer Research at MedUni Vienna have shown that the growth factor receptor FGFR3 increases the rate of growth and aggressiveness of hepatocellular carcinomas (liver cell cancer). Inhibition of this receptor could be a new and effective way of treating patients.
› Verified 3 days ago
| Entity Name | Midwest Pulmonary Critical Care & Sleep Consultants Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467951095 PECOS PAC ID: 5799048526 Enrollment ID: O20180514000039 |
News Archive
A drug typically used to treat depression and anxiety can significantly reduce joint pain in postmenopausal women being treated for early stage breast cancer, according to new SWOG research to be presented Friday at a special plenary presentation at the San Antonio Breast Cancer Symposium.
Scientists are reporting an in-depth validation of the discovery of the world's first mass producible, low-cost, organoclays for plastics. The powdered material, made from natural clay, would be a safer, more environmentally friendly replacement for the compound widely used to make plastics nanocomposites. A report on the research appears in ACS' Macromolecules, a bi-weekly journal.
The Bismarck Tribune reports on a new scheme "asking seniors to pay up for not having Part D coverage. The scammers have been calling beneficiaries saying they owe a penalty for not having the Part D prescription drug coverage and that they need to pay the fine right away, said a release from the office of the Insurance Commissioner" (1/20).
In a recent study, scientists from the Institute for Cancer Research at MedUni Vienna have shown that the growth factor receptor FGFR3 increases the rate of growth and aggressiveness of hepatocellular carcinomas (liver cell cancer). Inhibition of this receptor could be a new and effective way of treating patients.
› Verified 3 days ago
| Entity Name | Hospitalist Physicians Of Illinois, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396347761 PECOS PAC ID: 0941614044 Enrollment ID: O20210202000124 |
News Archive
A drug typically used to treat depression and anxiety can significantly reduce joint pain in postmenopausal women being treated for early stage breast cancer, according to new SWOG research to be presented Friday at a special plenary presentation at the San Antonio Breast Cancer Symposium.
Scientists are reporting an in-depth validation of the discovery of the world's first mass producible, low-cost, organoclays for plastics. The powdered material, made from natural clay, would be a safer, more environmentally friendly replacement for the compound widely used to make plastics nanocomposites. A report on the research appears in ACS' Macromolecules, a bi-weekly journal.
The Bismarck Tribune reports on a new scheme "asking seniors to pay up for not having Part D coverage. The scammers have been calling beneficiaries saying they owe a penalty for not having the Part D prescription drug coverage and that they need to pay the fine right away, said a release from the office of the Insurance Commissioner" (1/20).
In a recent study, scientists from the Institute for Cancer Research at MedUni Vienna have shown that the growth factor receptor FGFR3 increases the rate of growth and aggressiveness of hepatocellular carcinomas (liver cell cancer). Inhibition of this receptor could be a new and effective way of treating patients.
› Verified 3 days ago
| Entity Name | Insight Chicago Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881261006 PECOS PAC ID: 2860894706 Enrollment ID: O20210714002059 |
News Archive
A drug typically used to treat depression and anxiety can significantly reduce joint pain in postmenopausal women being treated for early stage breast cancer, according to new SWOG research to be presented Friday at a special plenary presentation at the San Antonio Breast Cancer Symposium.
Scientists are reporting an in-depth validation of the discovery of the world's first mass producible, low-cost, organoclays for plastics. The powdered material, made from natural clay, would be a safer, more environmentally friendly replacement for the compound widely used to make plastics nanocomposites. A report on the research appears in ACS' Macromolecules, a bi-weekly journal.
The Bismarck Tribune reports on a new scheme "asking seniors to pay up for not having Part D coverage. The scammers have been calling beneficiaries saying they owe a penalty for not having the Part D prescription drug coverage and that they need to pay the fine right away, said a release from the office of the Insurance Commissioner" (1/20).
In a recent study, scientists from the Institute for Cancer Research at MedUni Vienna have shown that the growth factor receptor FGFR3 increases the rate of growth and aggressiveness of hepatocellular carcinomas (liver cell cancer). Inhibition of this receptor could be a new and effective way of treating patients.
› Verified 3 days ago
| Entity Name | Advanced Pulmonary Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104544915 PECOS PAC ID: 1153799424 Enrollment ID: O20221116003114 |
News Archive
A drug typically used to treat depression and anxiety can significantly reduce joint pain in postmenopausal women being treated for early stage breast cancer, according to new SWOG research to be presented Friday at a special plenary presentation at the San Antonio Breast Cancer Symposium.
Scientists are reporting an in-depth validation of the discovery of the world's first mass producible, low-cost, organoclays for plastics. The powdered material, made from natural clay, would be a safer, more environmentally friendly replacement for the compound widely used to make plastics nanocomposites. A report on the research appears in ACS' Macromolecules, a bi-weekly journal.
The Bismarck Tribune reports on a new scheme "asking seniors to pay up for not having Part D coverage. The scammers have been calling beneficiaries saying they owe a penalty for not having the Part D prescription drug coverage and that they need to pay the fine right away, said a release from the office of the Insurance Commissioner" (1/20).
In a recent study, scientists from the Institute for Cancer Research at MedUni Vienna have shown that the growth factor receptor FGFR3 increases the rate of growth and aggressiveness of hepatocellular carcinomas (liver cell cancer). Inhibition of this receptor could be a new and effective way of treating patients.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sajid Mehmood, MD P.o. Box 458, Niles, MI 49120-0458 Ph: (269) 687-1136 | Dr Sajid Mehmood, MD 6800 State Route 162, Maryville, IL 62062-8521 Ph: (618) 288-5711 |
News Archive
A drug typically used to treat depression and anxiety can significantly reduce joint pain in postmenopausal women being treated for early stage breast cancer, according to new SWOG research to be presented Friday at a special plenary presentation at the San Antonio Breast Cancer Symposium.
Scientists are reporting an in-depth validation of the discovery of the world's first mass producible, low-cost, organoclays for plastics. The powdered material, made from natural clay, would be a safer, more environmentally friendly replacement for the compound widely used to make plastics nanocomposites. A report on the research appears in ACS' Macromolecules, a bi-weekly journal.
The Bismarck Tribune reports on a new scheme "asking seniors to pay up for not having Part D coverage. The scammers have been calling beneficiaries saying they owe a penalty for not having the Part D prescription drug coverage and that they need to pay the fine right away, said a release from the office of the Insurance Commissioner" (1/20).
In a recent study, scientists from the Institute for Cancer Research at MedUni Vienna have shown that the growth factor receptor FGFR3 increases the rate of growth and aggressiveness of hepatocellular carcinomas (liver cell cancer). Inhibition of this receptor could be a new and effective way of treating patients.
› Verified 3 days ago
Dr. Christopher Farrar, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 6800 State Route 162, Maryville, IL 62062 Phone: 618-288-4095 Fax: 618-288-2984 | |
Syed M Arshad, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 2227 Vadalabene Dr, Suite 100, Maryville, IL 62062 Phone: 618-288-1140 | |
Barbara Joy Foner, MD MPH FCCP ABSM Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 6812 State Rte 162 Suite 202, Maryville, IL 62062 Phone: 618-288-6844 Fax: 618-288-6852 | |
Dr. Rafe M Heng, D.O., FACC Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 6812 State Rte 162 Suite 202, Maryville, IL 62062 Phone: 618-288-1748 Fax: 618-288-1768 | |
Dr. Saulat Mushtaq, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 2227 Vadalabene Dr, Maryville, IL 62062 Phone: 618-391-5046 Fax: 618-391-5049 | |
Sujata Sitaula, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 2133 Vadalabene Dr Ste 1, Maryville, IL 62062 Phone: 618-288-4350 Fax: 618-288-4296 |